Melanoma-associated antigen 3; MAGE-3
CAT No: ta-459
Synonyms/Alias:Melanoma-associated antigen 3 (167-176); MAGE-3 (167-176)
MAGE-3 (167-176) is a synthetic peptide fragment derived from the melanoma-associated antigen 3 (MAGE-3) protein, specifically corresponding to amino acid residues 167 through 176 of the full-length sequence. As a member of the cancer-testis antigen family, MAGE-3 is predominantly expressed in various malignant tissues but is absent from most normal somatic cells, making it a valuable target in tumor immunology research. The 167-176 epitope is of particular interest due to its immunogenic properties and its recognized role in antigen presentation pathways, which has positioned it as a key tool for studies focused on cellular immune responses and peptide-MHC binding interactions. Researchers utilize this peptide to dissect the molecular mechanisms underlying tumor antigen recognition, T cell activation, and immune surveillance, contributing to the broader understanding of tumor immunobiology.
Epitope Mapping: The 167-176 fragment of MAGE-3 serves as a defined epitope in studies aiming to map antigenic determinants recognized by cytotoxic T lymphocytes (CTLs). By incorporating this peptide into in vitro assays, researchers can precisely identify T cell receptor (TCR) specificity and delineate the minimal peptide sequence required for effective immune recognition. Such mapping is essential for elucidating the molecular basis of tumor antigenicity and provides a foundation for further exploration of immune escape mechanisms in cancer cells.
Immunogenicity Assessment: In experimental immunology, the peptide is widely used to evaluate the immunogenic potential of tumor-associated antigens. By loading antigen-presenting cells (APCs) with the MAGE-3 (167-176) sequence, investigators can measure the activation and proliferation of antigen-specific T cell populations. These assays facilitate the comparative analysis of peptide immunogenicity, supporting the rational design of immunotherapeutic strategies and the optimization of antigen selection for experimental vaccine platforms.
Peptide-MHC Binding Studies: The defined sequence of this peptide allows for detailed investigation into peptide-major histocompatibility complex (MHC) interactions. Researchers employ the 167-176 epitope to characterize binding affinities and stability within MHC class I molecules, which is critical for understanding the structural requirements of antigen presentation. These insights are fundamental for predicting peptide binding motifs, modeling immune recognition, and advancing computational approaches in immunoinformatics.
T Cell Functional Assays: Functional studies involving the MAGE-3 (167-176) peptide enable the assessment of T cell effector functions in vitro, including cytokine secretion, cytotoxic activity, and proliferation. By stimulating T cells with this defined epitope, scientists can monitor downstream signaling events, characterize functional avidity, and evaluate memory responses. Such assays are instrumental for validating the specificity and potency of engineered T cell receptors or for screening immune-modulating compounds in preclinical research.
Peptide-Based Assay Development: The unique antigenic properties of the MAGE-3 167-176 peptide make it a valuable reference standard in the development and validation of peptide-based immunoassays. It is frequently used as a positive control in enzyme-linked immunospot (ELISpot), flow cytometry, and tetramer staining protocols designed to detect antigen-specific T cells. Its consistent performance in these platforms supports assay reproducibility, quality control, and the benchmarking of novel immunological reagents, thereby enhancing the reliability of experimental readouts in immunological research.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More